|
|
|
|
LEADER |
00000cam a2200000Ia 4500 |
001 |
EBSCO_ocn655841253 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
100813s2010 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d EBLCP
|d OCLCQ
|d MHW
|d YDXCP
|d OCLCQ
|d AU@
|d OCLCA
|d OCLCO
|d OCLCA
|d UKDOC
|d NLGGC
|d OCLCQ
|d DEBSZ
|d OCLCQ
|d D6H
|d AGLDB
|d OCLCO
|d JBG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCA
|d OCL
|d OCLCO
|d VNS
|d VTS
|d OCLCO
|d TOF
|d OCLCO
|d OCLCA
|d STF
|d OCLCO
|d M8D
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|
019 |
|
|
|a 781367635
|a 847412331
|a 954579743
|
020 |
|
|
|a 9781846926112
|q (electronic bk.)
|
020 |
|
|
|a 1846926114
|q (electronic bk.)
|
020 |
|
|
|a 9781846920264
|
020 |
|
|
|a 1846920264
|
029 |
1 |
|
|a AU@
|b 000048824030
|
029 |
1 |
|
|a AU@
|b 000058023245
|
029 |
1 |
|
|a DEBBG
|b BV043096581
|
029 |
1 |
|
|a DEBSZ
|b 421702990
|
029 |
1 |
|
|a AU@
|b 000051408869
|
035 |
|
|
|a (OCoLC)655841253
|z (OCoLC)781367635
|z (OCoLC)847412331
|z (OCoLC)954579743
|
050 |
|
4 |
|a RC921
|b .R479 2010eb
|
072 |
|
7 |
|a MED
|x 083000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.72306
|2 22
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Rheumatology /
|c edited by Michael Doherty.
|
246 |
1 |
4 |
|a Therapeutic strategies in rheumatology
|
260 |
|
|
|a Oxford :
|b Clinical Pub.,
|c 2010.
|
300 |
|
|
|a 1 online resource (viii, 210 pages).
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Therapeutic strategies
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Editor; Contributors; Acknowledgement; Chapter 1: Early arthritis; Chapter 2: Established rheumatoid arthritis; Chapter 3: Beyond anti-TNF: other biological drugs in inflammatory arthritis; Chapter 4: Pharmacogenetics of inflammatory arthritis; Chapter 5: Psoriatic arthritis; Chapter 6: Therapy of ankylosing spondylitis; Chapter 7: Systemic lupus erythematosus; Chapter 8; Antiphospholipid syndrome; Chapter 9: Progress in the therapy of systemic sclerosis; Chapter 10: Inflammatory myositis; Chapter 11: Disease-modifying drugs in osteoarthritis; Chapter 12: Management of gout.
|
520 |
|
|
|a Offers a global perspective on current approaches to diagnosis and therapy for musculoskeletal and joint disease, reporting on the latest trial results and published literature that will have an impact on clinical practice. Experts in each of these fields guide the reader through the many options now available to clinicians managing rheumatological disease, providing a clear account of current best practice and future directions.
|
588 |
0 |
|
|a Print version record.
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Rheumatism.
|
650 |
|
0 |
|a Arthritis.
|
650 |
|
0 |
|a Rheumatism
|x Complications
|x Treatment.
|
650 |
1 |
2 |
|a Rheumatic Diseases
|x diagnosis
|
650 |
1 |
2 |
|a Rheumatic Diseases
|x therapy
|
650 |
2 |
2 |
|a Diagnostic Techniques and Procedures
|
650 |
|
2 |
|a Rheumatic Diseases
|
650 |
|
6 |
|a Rhumatisme.
|
650 |
|
6 |
|a Rhumatisme
|x Complications et séquelles
|x Traitement.
|
650 |
|
6 |
|a Diagnostics
|x Méthodologie.
|
650 |
|
7 |
|a MEDICAL
|x Rheumatology.
|2 bisacsh
|
650 |
|
7 |
|a Arthritis.
|2 fast
|0 (OCoLC)fst00817097
|
650 |
|
7 |
|a Rheumatism.
|2 fast
|0 (OCoLC)fst01097001
|
700 |
1 |
|
|a Doherty, Michael,
|d 1951-
|
776 |
0 |
8 |
|i Print version:
|t Rheumatology.
|d Oxford : Clinical Publishing, 2010
|z 9781846920264
|w (OCoLC)642670725
|
830 |
|
0 |
|a Therapeutic strategies.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=330382
|z Texto completo
|
938 |
|
|
|a 123Library
|b 123L
|n 3054
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL601464
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 330382
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 3421195
|
994 |
|
|
|a 92
|b IZTAP
|